TUBULOINTERSTITIAL NEPHRITIS

This adverse event was reported 18761 times

These drugs are most commonly taken by patients reporting TUBULOINTERSTITIAL NEPHRITIS:

# Drug Count
0 OMEPRAZOLE MAGNESIUM 5363
1 ESOMEPRAZOLE MAGNESIUM 4259
2 LANSOPRAZOLE 4194
3 PANTOPRAZOLE SODIUM 2998
4 OMEPRAZOLE 2501
5 DEXLANSOPRAZOLE 2191
6 IBUPROFEN 1540
7 FUROSEMIDE 1525
8 PANTOPRAZOLE 1521
9 IBUPROFEN 200MG 1452
See all common drugs associated with TUBULOINTERSTITIAL NEPHRITIS

TUBULOINTERSTITIAL NEPHRITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TETRAHYDROZOLINE HYDROCHLORIDE 81 0.2755
1 EPINEPHRINE HYDROCHLORIDE 77 0.1624
2 FERRIC SULFATE 12 0.1500
3 OMEPRAOLE, SODIUM BICARBONATE 37 0.1160
4 VANCOMYCIN HYDROCHLORIDE 836 0.1000
5 ALBENDAZOLE 136 0.0714
6 MINERAL OIL 91 0.0613
7 FAMOTITINE 175 0.0594
8 DEXLANSOPRAZOLE 2191 0.0525
9 CLINDAMYCIN PHOSPHATE 262 0.0475
See all drugs enriched for association with TUBULOINTERSTITIAL NEPHRITIS

TUBULOINTERSTITIAL NEPHRITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anthelmintic [EPC] 137 0.0471
1 Provitamin D2 Compound [EPC] 711 0.0239
2 Bismuth [EPC] 116 0.0208
3 Guanylate Cyclase-C Agonist [EPC] 40 0.0193
4 Programmed Death Receptor-1 Blocking Antibody [EPC] 1739 0.0176
5 Tubulin Inhibiting Agent [EPC] 5 0.0172
6 Nitrofuran Antibacterial [EPC] 238 0.0135
7 Glycopeptide Antibacterial [EPC] 813 0.0124
8 Proton Pump Inhibitor [EPC] 6112 0.0104
9 Actinomycin [EPC] 23 0.0104
See all drug classes enriched for association with TUBULOINTERSTITIAL NEPHRITIS